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Abstract
Introduction Glycoproteomics is undergoing rapid devel-
opment, largely as a result of advances in technologies for
isolating glycoproteins and analyzing glycan structures.
However, given the number and diversity of glycans, there
is need for new technologies that can more rapidly provide
differential carbohydrate–protein structural information on
a large scale. We describe a new microarray platform based
on a label-free imaging ellipsometry technique, which
permits simultaneous detection of multiple glycoprotein–
lectin interactions without the need for reporter labels,
while still providing high throughput kinetic information at
much lower cost. Our results demonstrate the utility of
LFIRE™ (Label-Free Internal Reflection Ellipsometry) for
the rapid kinetic screening of carbohydrate–lectin recogni-
tion. The technology was also used to evaluate the benefits
of the lectin immobilization format using multi-lectin
affinity chromatography (M-LAC) to capture glycoproteins
(with enhanced binding strength or avidity) from biological
samples. Using a printed panel of lectins, singly or in
combination, we examined the binding characteristics of
standard glycoproteins.
Results and Discussion Using kinetic measurements, it was
observed that the binding strength of lectins to carbohy-
drates is enhanced using a multi-lectin strategy, suggesting
that improved selectivity and specificity can lead to
increased functional avidity. The data presented confirm
that this label-free technology can be used to effectively
screen single or combinations of lectins. Furthermore, the
combination of LFIRE™ and M-LAC may permit more
rapid and sensitive identification of novel biomarkers based
on carbohydrate changes in glycoproteins, and lead to a
better understanding of the connections of glycan function
in cellular mechanisms of health and disease.
Keywords Lectins . Glycoproteome .
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Introduction
Glycosylation of proteins is a nearly ubiquitous post-
translational modification observed in eukaryotic organ-
isms. It is estimated that roughly half of the mammalian
proteome consists of glycoproteins [1]. Glycosylation plays
a fundamental role in a diverse set of biological processes
such as immune response, cellular regulation, and cell
signaling [2]. Alterations in glycosylation patterns have
been linked to the progression of several diseases, most
notably cancer [3, 4].
In recognition of the importance of glycosylation, many
proteomics researchers have turned their attention to the
glycoproteome in search of markers for disease diagnosis
and treatment. These include candidate biomarkers that
change in either the abundance of the glycoprotein or the
glycan structure itself, or both. However, the study of
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glycosylation is a challenging undertaking; this can partly
be attributed to the complexity of glycan structures.
Glycans can exist in highly heterogeneous forms, with a
variety of possible structural configurations and linkage
types; they are present as N- or O-linked and can occupy
several sites on a glycoprotein. Several methodologies are
available to characterize glycostructures, such as those
based on anion exchange separation of fluorescently tagged
glycans [5], mass spectrometry using nano-LC coupled to a
linear ion trap Fourier transform mass spectrometer (nano-
LC-LTQ/FTMS) [6], and MALDI-TOF [7]. In addition,
carbohydrate–protein interactions have typically been stud-
ied using kinetic measurements by surface plasmon
resonance (SPR) [8, 9] and frontal affinity chromatography
using lectins [10]. Previously, methods focused on carbo-
hydrate arrays, where the low-affinity lectin–carbohydrate
interactions are much simpler and easier to model but do
not allow researchers to directly examine changes in
glycosylation of proteins [11]. In the past few years, lectin
microarrays have become increasingly popular. Kuno et. al.
reported using a new microarray procedure based on
evanescent-field-excited fluorescence detection of lectin
microarrays as a strategy for glycan profiling to obtain
kinetic information in a multiplexed fashion [12]. Technol-
ogies capable of analyzing multiple lectin–glycoprotein
interactions in parallel in a single experiment and in a high-
throughput manner offer increased utility, as reported
previously [8, 11, 12]. Such technologies can be utilized
to efficiently study disease-associated glycosylation
changes on a proteome scale to further accelerate the quest
for “glyco-markers” of clinical value.
Lectins comprise a special family of carbohydrate-
binding proteins distributed widely in the plant and animal
kingdom. After a boom in lectin discovery and character-
ization in the 1970s, many lectins became commercially
available for research purposes [13]. Lectins have been
essential for the understanding of carbohydrate-based
biological recognition. The use of lectin affinity chroma-
tography has gained popularity in glycoproteomics as a
way to simplify the sample before analysis, to enrich
specific glycoprotein content in blood samples. In addition,
the differential specificity of lectins allows specific pop-
ulations of glycoproteins to be targeted and may permit
changes in glycosylation to be detected. The wide variety of
lectins available commercially enables many different
subsets of glycans to be investigated. Technologies such
as the multi-lectin affinity chromatography (M-LAC) [14]
or serial lectin affinity chromatography (S-LAC) [15] have
been both used for interrogating the glycoproteomes of
human plasma, serum, urine, and cellular lysates. Alterna-
tively, lectin or carbohydrate arrays have also been
introduced to study changes in the glycoproteome. A
significant benefit of array technologies is that they require
very little sample, and a wide spectrum of ligand
interactions may be screened rapidly in parallel format.
We (W.H., M.H., M.K.) developed the concept of M-
LAC or multi-lectin affinity chromatography as a way of
improving the specificity/selectivity of glycoproteins iso-
lated from complex biological specimens. We have dem-
onstrated previously [16, 17] that the M-LAC column has
excellent enrichment capabilities for glycoproteins from
human plasma or serum. This technology provides an
approach for detecting up or down regulation of glycosy-
lated and non-glycosylated proteins from the same sample.
The advantage of M-LAC over single or serial lectin
capture may lie in its more complete single-step capture and
enrichment of low level glycoproteins from complex
samples, such as serum or plasma. We also have demon-
strated that M-LAC can be used to monitor changes in
protein glycosylation. This is achieved by step-wise elution
of glycoproteins using three different sugar displacers
specific for each lectin in the M-LAC column. For example,
it has been demonstrated that the treatment of transferrin
with neuraminidase to remove sialic acid causes a shift in
distribution of transferrin isoforms between fractions eluted
with three different displacers [18].
The combination of specificities of the lectins as found
in the M-LAC column potentially can lead to a functional
advantage due to multi-valency and an increase in binding
strength over single lectins. It would be advantageous,
however, to have a procedure for efficiently optimizing the
type and ratio of lectins used in a specific sample set. In this
report, we used a prototype imaging instrument (LFIRE™)
based on the principles of ellipsometry, a widely used and
versatile optical technique for measuring the thickness and
optical parameters of ultra-thin films, which can be
calibrated directly to the amount of material bound on a
wide range of surfaces. The theory of ellipsometry is
discussed extensively [19, 20] and will not be addressed in
detail here. Although the underlying theory of ellipsometry
has been understood for over a century [21], it was not until
the 1960s that ellipsometers were used routinely in the early
computer industry to characterize the growth of thin
metallic and semi-conductor films. In the life sciences,
there were a few pioneering works using ellipsometry for
immunological studies and for measuring the kinetics of
protein adsorption. A review of these works from 1972 [22]
demonstrated the use of ellipsometry in only a small
number of applications. Over a decade later, some of the
first quantitative comparisons, between ellipsometry and
radiolabeling techniques, of the surface mass density of
adsorbed layers of proteins were demonstrated [23]. During
the 1990s, imaging ellipsometry and imaging SPR had been
developed and used to study the film thickness of biological
layers [24–28]. Whereas imaging SPR focuses on reflected
light intensity, LFIRE™ is characterized by the rapid time-
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resolved detection of polarization changes of a reflected
monochromatic light beam due to interactions with
biomolecules near a glass–liquid interface. The resultant
measured phase shift between s-polarized and p-polarized
light is more sensitive to adsorbed protein layers than the
reflected light intensity signal from imaging SPR. In
addition, SPR imaging requires a metallic layer such as
gold, which limits the spatial resolution of images due to
the spatial extent of the excited surface plasmons [29].
The LFIRE™ measurements are performed in situ with
high spatial resolution, so that the changes in thickness
and refractive index due to specific binding events within
the array may be measured. Data is acquired several times
per minute so kinetics may be determined for a high
number of targets in parallel in both fluid cell and well-
plate formats.
The LFIRE™ technology was used as a proof of concept
to investigate the interaction and kinetics of standard
glycoproteins with single and combinations of lectins
typically used in the M-LAC format. It was determined that
this approach could efficiently measure the binding kinetics
of both single and combinations of lectins. The ability to
perform multiplexed real-time measurement of binding
kinetics adds a new dimension to the field of glycomics by
allowing the analyst to probe multiple samples and combi-
nations of lectins to interrogate carbohydrate–lectin inter-
actions of clinical relevance. Post-translational changes in
the carbohydrate structure resulting in either trimming or
addition of sugars will affect the binding kinetics, a
measurement that can be further used to identify and
characterize new biomarkers for clinical applications. This
will have broad impact in the study of diseases such as
cancer, where surface, transport, and secreted proteins all
show significant changes in glycosylation.
In this work, we describe the development of a new
technology platform (LFIRE™) based on the principles of
ellipsometry. We applied it to lectin microarrays and
demonstrate that this technology can be a useful tool for
quantitative and qualitative analysis of complex kinetic
interactions between various combinations of lectins and
different carbohydrate motifs. Furthermore, the combina-
tion of M-LAC and LFIRE™ technologies can be very
powerful for high throughput ligand selection and/or
characterization of glycoprotein biomarkers that can be
isolated from patients with defined diseases.
Materials and Methods
Lectin Array Construction
Lectins concanavalin A (ConA), wheat germ agglutinin
(WGA), and jacalin supplied by Vector Labs (Burlingame,
CA, USA) were reconstituted in M-LAC binding buffer
(25 mM Tris, pH 7.4, 0.5 M sodium chloride, 1 mM
MnCl2, 1 mM CaCl2, and 0.05% sodium azide) for
storage. To remove Tris, the samples were dialyzed into
50 mM 4-2-hydroxyethyl-1-piperazineethanesulfonic ac-
id-buffered saline, 0.005% Tween 20 (HBST), supple-
mented with 1 mM manganese chloride and calcium
chloride immediately before printing samples. All lectins
were diluted to 0.667 mg protein per milliliter in
phosphate-buffered saline (PBS), pH 7.5, for printing on
high-sensitivity LFIRE™ optical slide substrates, which
include a proprietary optical coating (Maven Biotechnol-
ogies) under a custom polyethylene glycol (PEG)-based
hydrogel N-hydroxysuccinimide ester (NHS)-terminated
surface chemistry (Accelr8 Technology Corporation, Den-
ver, CO, USA). Mono-amine-terminated 5-kDa PEG was
obtained from Nektar Therapeutics, Huntsville, AL, USA.
Porcine thyroglobulin, hen egg ovalbumin, bovine fetuin,
and asialofetuin glycoproteins were supplied by Sigma-
Aldrich, St. Louis, MO. With a printing program devel-
oped by Maven, the SpotBot MicroArrayer, and a single
Stealth946 pin (Telechem Inc., Sunnyvale, CA, USA),
each slide was printed with two identical arrays of 20
materials including lectins and reference spots, four
replicates each, 250 μm center-to-center, at 50–60%
relative humidity, 25–27°C, yielding ∼100-μm-diameter
spots. A single pin loading for all slides in each batch
reduced variation and allowed maximum flexibility in spot
location. Microarrays were immediately packaged in
moisture-proof bags with silica gel desiccant and stored
at 4°C until use.
LFIRE™ Detection System
For the current experiments, LFIRE™ was used in its flow-
cell configuration to illuminate the surface of a microscope
slide, printed with a microarray of lectins, from below
with elliptically polarized light from a 1-W, 455-nm LED.
Figure 1 is a schematic of the instrument, a modified-
phase-modulated imaging ellipsometer. The light is ellipti-
cally polarized by the two optical elements, a polarizer and
retarder, which is a quarter-wave plate. The 0.75-in.-
diameter collimated beam enters a BK7 prism, which is
optically coupled with index-matching oil (Cargille, Cedar
Grove, NJ, USA) to the underside of the slide. The large
incidence angle (∼63°) allows the light to be totally
internally reflected from the glass/liquid interface, creating
an evanescent wave [30] that interacts with refractive index
changes within the first 200 nm of the liquid as glyco-
proteins approach and are bound by the printed lectins. An
image of the reflected beam is projected onto a charge-
coupled device camera (Cooke 1600), while the polarizer
and retarder are rotated through eight discrete angles called
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phases. For each phase in the phase modulation, 15
individual images are averaged together for noise reduction.
Those averaged images are then mathematically recon-
structed into two final images (X and Y) every 15 s for the
experimental data. Changes in the Y-image are proportional
to the phase shift (retardance) created by the adsorbing
molecular layer. This phase shift is in turn proportional to
layer thickness or mass density of adsorbed molecules on
the surface. The current technology has the sensitivity to
detect changes in surface mass density of 3 pg/mm2, which
is roughly 25 fg of material in each 100-μm-diameter
microarray spot. This translates to analyte concentrations of
20–40 pM readily detected in a typical antibody–antigen
interaction. The instrument is currently capable of capturing
the dynamic molecular surface density changes over a
maximum area of 12×12 mm of the substrate slide surface
every 30 s in a flow-cell configuration or with microwells,
with 7.4-μm spatial resolution over the entire field of view.
Smaller areas can be imaged more rapidly, and all of the
data presented in this paper were taken at 15-s intervals. A
second prototype is currently in development to gather
microarray data every 3 s for higher throughput applica-
tions requiring 96-well and 384-well plates.
Experimental Setup
Just before use, lectin microarray slides were washed with
an aggressive spray of PBS-T (0.05 M PBS with 0.05%
Tween 20) to remove all loosely bound material, rinsed
briefly with distilled water, and dried with a dry nitrogen
stream. Slides were attached to LFIRE™ disposable twin
flow cells and microfluidic interconnect assembly (Fig. 1),
optically mated to a BK7 prism with index-matching fluid,
enclosed in the LFIRE™ TEC environmental control
fixture, and inserted in the LFIRE system. The flow cells
were filled with M-LAC binding buffer, temperature set to
25±0.05°C, and equilibration was obtained before data
acquisition. The signal stabilized rapidly in 15 min due to
hydrolysis and quenching of NHS moieties on the surface
by the buffer.
To test the surface coating supplier’s claim that the
surfaces may not require blocking, 50 μg/ml human serum
albumin (HSA) was injected; flow was stopped and allowed
to incubate for 30 min. HSA did not bind significantly
(<1% of a monolayer) to the substrate, lectins, or controls
(data not shown). Measuring molecular binding at the
sensitivity limits of the instrument requires blocking,
normalization to negative control spots such as HSA, or
both for this particular surface given that, even within the
small panel of glycoproteins, nonspecific binding was
observed to the bare substrate but not to the negative
control spots.
Lectin/Glycoprotein Kinetic Assay
The measurement area was set to encompass both arrays,
each in its own flow cell, for simultaneous analysis of two
glycoproteins. The running buffer for all experiments was
M-LAC binding buffer flowing at 25 ul/min. All data was
captured as 16-bit TIFFs. After 3 min of lead-in time to
establish the baseline, 10 μM glycoprotein samples in the
same buffer were injected at a flow rate of 25 μl/min, for a
net incubation (dwell) time of 4 min. The arrays were
rinsed continuously with running buffer only for 15 min to
Fig. 1 Schematic drawing of the LFIRE™ optical setup and associated liquid handling for the flow cell configuration
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determine off-rates. The final measurements constituted the
arbitrary “endpoints” for this study, although most samples
still demonstrated some dissociation. All of the glycopro-
teins except ovalbumin were eluted from the arrays by a
30-min exposure to 20 mM Tris, 0.5 M NaCl, 0.17 M
methyl-a-D-mannopyranoside, 0.17 M N-acetyl-glucos-
amine, and 0.27 M galactose, pH 7.4. Analysis of the
images was done using ImageJ v1.34 s (NIH/public
domain), and IgorPro (WaveMetrics, Inc, Lake Oswego,
OR, USA) was used for data analysis.
Binding of Thyroglobulin on ConA and M-LAC Columns
Lectins were immobilized onto styrene–divinylbenzene co-
polymers coated with a cross-linked polyhydroxylated
polymer (POROS™). HPLC support using the Schiff base
method for covalent immobilization (aldehyde activated
media, Applied Biosystems) was used according to the
instructions provided by the manufacturer. HPLC columns
were packed with either the immobilized Con A or with a
mixture of the three individual lectins (ConA, WGA, and
JAC) combined in a 1:1:1 (23:8.0:11 mg) molar equivalent
ratio to make the M-LAC column. The amount of Con A in
the single lectin affinity column was the same as that of the
M-LAC support.
Thyroglobulin protein was prepared by dissolving 20 mg
in 2 ml of M-LAC binding buffer for a final concentration
of 10 mg/ml; 5 mg of the thyroglobulin solution was
injected onto each of the ConA and M-LAC columns. To
increase the residency time, the protein was loaded slowly
(0.05 ml/min). The flow rate was then increased to 2.5 ml/
min. Unbound protein was washed with 10 column
volumes (CV) of binding buffer, and the bound protein
was eluted with 11 CV of 100 mM acetic acid at pH 4.0.
The lectin columns were neutralized with 11 CV of
neutralization buffer (0.5 M Tris, 1 M sodium chloride,
and 0.05% sodium azide, pH 7.4) and equilibrated with
10 CV of binding buffer.
Results and Discussion
A sample image is shown in Fig. 2 of the lectin microarray,
printed in quadruplicate, before incubation with glycopro-
teins. The data is presented in relative ellipsometry units
(REUs), the physical meaning of which is described below.
Each lectin was printed in quaduplicate with the mean and
standard deviation calculated for each set of four replicates.
For this particular study, the average of all mean values was
9.5 REU above background, and the average standard
deviation was 0.45 REU, considerably larger than the
temporal noise of a single spot kinetic trace (0.0045 REU).
The spot to spot coefficient of variation was in the range
0.2–11% for each set of four replicates with an average CV
of 4.9%.
Ellipsometry generally gives an average thickness and
refractive index value of the protein layer. Feijter’s formula
is a good approximation between surface mass density and
biofilm thickness below.




where M is the mass density in ng/mm2, d is the thickness
of the protein layer in nm, np is the index of refraction of
the protein layer, ns is the index of the solvent, and dn/dc is
a measure of how the index of the protein changes as a
function of protein concentration. This value is given by
many sources to be 0.182 cm3/g [31]. For SPR measure-
ments, an accepted average is that 1 ng/mm2 is equivalent
to a 1-nm layer of protein film, which has been confirmed
numerous times by SPR [32], quartz–crystal microbalance
and AFM measurements. For LFIRE™, 1 ng/mm2
∼2.6 REU based on a spotted dilution series of target
molecules with concentrations measured by ultraviolet or
visible spectroscopy . Figure 2 also depicts a novel feature
of LFIRE that permits quality-control assessment of spot
Fig. 2 Initial LFIRE raw image of the lectin microarray in situ and
prior to incubation with glycoproteins. Intensity is directly propor-
tional to the surface density of bound protein, allowing evaluation of
array quality and correlation with binding measurements. The signal is
converted into relative ellipsometry units (REUs), and the color bar
inset establishes the relationship between color and signal intensity,
which is proportional to the amount of lectin on the surface. Scale
bar=250 μm
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morphology before initiation of the ligand-binding event.
Table 1 describes the relative location of lectins, lectin
combinations, and control spots.
Figure 3a through d represents the comparative lectin
binding patterns on microarrays of four different glycopro-
teins. The error bars for this data set was determined to be
±0.1 REU based on the full range of non-specific binding
measured by the various negative control spots (data not
shown). HSA was chosen as the negative control (assay
blank) because those spots were observed to show minimal
reactivity with glycoproteins. Thus, the kinetic curves for
HSA were subtracted from the kinetic curves for every spot
in the array. The data are sorted in ascending order of
binding for fetuin, which has three N-linked and three
O-linked oligosaccharides, each existing in multiple glyco-
sylation isoforms. The literature suggests that WGA
preferentially binds n-acetylglucosamine (GlcNAc), which
is present in fetuin, but the reduced binding (∼50%) of
asialofetuin suggests that binding is partly dependent on
other glycan interactions as well as sialic acid. A test of the
specificity of the lectin array is the altered binding order for
asialofetuin relative to fetuin, where the increased binding
by jacalin is possibly due to increased but not optimal
exposure of any of the following: Gal and GalNAc residues
or the O-linked glycan core, Galβ1–3GalNAc. ConA binds
fetuin and asialofetuin weakly, presumably due to minimal
exposure of mannose, a finding supported by the under-
standing of fetuin’s glycan structure [33, 34] and by surface
plasmon resonance studies [35]. Ovalbumin bound weakly
to most of the lectins or their combinations and demon-
strated high levels of binding to the bare substrate. Relative
binding of ovalbumin to WGA and ConA, and the low
binding of ovalbumin in general, supports findings in the
literature [11, 36]. Thyroglobulin showed a different
binding pattern from the other glycoproteins, most notably
no binding with jacalin, consistent with the absence of
GalNAc residues in porcine thyroglobulin and the unavail-
ability of terminal Galβ in the native sialated glycoprotein
Fig. 3 a–d Binding of four glycoproteins to 14 lectins or lectin
combinations after 4-min incubation and 15 min rinse with running
buffer to remove non-specific binding. The lectins are arranged in
ascending order in terms of the binding to fetuin, and the same order
was repeated for the remaining graphs. The substrate represents areas
of the surface not containing lectin and is a measure of non-specific
binding. Mixtures are given by three numbers separated by colons and
represent the concentration ratio of ConA/WGA/jacalin within each
microarray spot normalized to ConA concentration in milligrams per
milliliter. M-LAC is an equimolar ratio of the three lectins
Table 1 Lectin microarray printing map, with each lectin or reference
spot printed in quadruplicate
Column 1 Column 2
Human serum albumin Protein A/G
5 kDa amino-PEG ConA/WGA/Jac 0.11:0.22:0.33
ConA/WGA/Jac 0.23:0.29:0:0.17 ConA/WGA/Jac 0.34:0.12:0.17






Human serum albumin BPL
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[37]. Thyroglobulin also bound to the substrate, indicating
that studies with glycoproteins require physical blocking of
the substrate. Further work is necessary to devise blocking
strategies that do not interfere with glycan binding, as
common blocking agents such as casein and bovine serum
albumin could introduce artifacts. Jacalin’s high binding of
asialofetuin relative to WGA and ConA has been demon-
strated previously with lectin arrays detected by total
internal reflection fluorescence scanning [12]. The obser-
vation that the binary combination of jacalin and WGA
binds asialofetuin equivalently to the binary combination of
jacalin and ConA is novel.
Figure 4a through d shows the differential images of
representative lectin spots in the arrays for each of the four
glycoproteins tested. Each pair of columns can be matched
with the spot ID pattern in Table 1. The brightness of the
spots is directly related to the amount of glycoprotein bound
and is quantitated by LFIRE™. Clearly, each glycoprotein
yields a distinctly different spot pattern, even between fetuin
and asialofetuin, which differ only in the presence or absence
of terminal sialic acids. Qualitatively, the data suggests that
lectin fingerprints could be used for rapid detection of new
clinically significant biomarkers in less than 5 min for
glycoprotein concentrations in the low micromolar range.
Figure 5 depicts kinetic curves chosen from two of the
lectin spots, each interacting with two of the glycoprotein
samples, which represents just four of the total 320
interactions studied. As mentioned above, the glycoproteins
were introduced into the flow cells at concentrations of
10 μM each for a period of 4 min. Although this is
insufficient time for the binding to reach equilibrium,
relative on and off rates can still be obtained. Before the
curves are analyzed, the curves from negative control spots
were subtracted from the data to remove changes in the
bulk refractive index of the liquid as it changed from buffer
to glycoprotein solution and back to buffer again. Spots of
human serum albumin were good negative controls for all
four glycoproteins. The REU signal is proportional to
surface mass density, just as in an SPR system, and
conventional curve fits are done to extract kinetic param-
eters such as on-rate, ka, off-rate, kd, and affinity, KA=ka/kd,
which were given in units of inverse molarity. The signals
were analyzed using the method of Karlsson et al. [38],
which has been the basis of analysis software for surface-
based molecular interactions for almost two decades. The
derivation of Eqs. 2 and 3 is based on the simple 1:1
Langmuir interaction model Aþ B, ABð Þ, constraining
the kinetic rate constants to a single value [39]. Although
the complexity of the data suggests that a more complex
model would be needed for an accurate determination of
kinetic constants, increasing the number of fit parameters
without understanding the source of interaction complexity
(i.e., sample heterogeneity, surface conformational changes,
multivalent binding, etc.) can produce confounding results.
Using the simplified model, the calculated rate constants in
this paper should be considered qualitative. In Figure 5,
curves were fit in two separate regions. The adsorption
region (t=0–225 s) was fitted using Eq. 2.
R tð Þ ¼ R0 þ Rmax 1 e  Ckaþkdð Þtð Þ
 
ð2Þ
Fig. 4 a–d Differential (endpoint minus baseline) image of columns 4
and 5 from Fig. 2, so as to show one spot of each lectin. a Fetuin, b
asialofetuin, c ovalbumin, and d thyroglobulin, each after 4-min
incubation and 15-min washing; scale bar=250 μm. The spot ID is
shown in Table 1
Fig. 5 Kinetic data for fetuin and asialofetuin binding to WGA and
jacalin. The fitted curves from the data are used to calculate the
affinity, KA, equal to the association constant divided by the
dissociation constant
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where R0 is a constant, Rmax is the maximum equilibrium
binding at high glycoprotein concentration, C is the
concentration of fetuin or asialofetuin during the reaction,
ka is the adsorption coefficient in units of M
−1 s−1, and kd is
the desorption coefficient in units of s−1. The desorption
region (t>225 s) was fit using Eq. 3.
R tð Þ ¼ C þ Ae kd tð Þ ð3Þ
The chi-square value was determined for each curve to
determine the quality of the fit. The largest value was 95,
which should be compared to the number of data points in
the fitting function, 200 in this analysis. As long as the chi-
square value is lower than the number of data points, this
can be considered a good fit [40]. The low chi-square value
of the fits demonstrates that conventional kinetic analysis
can be applied to lectin microarrays using LFIRE technol-
ogy in a highly multiplexed fashion. The affinity values in
Fig. 5 were average values calculated from each of four
replicate spots. To get some sense of the variability,
affinities were calculated for individual spots showing a
range of ±7–8% about the mean for each interaction. Thus,
the calculated affinity for fetuin to WGA is 5.1×105±0.4×
105 M−1. The variability for asialofetuin to jacalin was
±0.7×105 M−1; for fetuin to jacalin, ±0.4×105 M−1; and
finally, for asialofetuin to WGA, ±0.3×105 M−1. Thus, in
this experiment, the affinities between fetuin and WGA
versus jacalin were too close to distinguish based on
kinetics, although substantially, more fetuin was bound to
WGA. In the case of asialofetuin, the affinity for jacalin
was clearly higher compared to WGA. This difference
suggests that asialofetuin, produced by desialation of fetuin,
may expose more galactose residues that are recognized by
jacalin. The reproducibility of microarray data is based on a
Fig. 6 Dissociation of fetuin from the lectins after introducing 20 mM
Tris, 0.5 M NaCl, 0.17 M methyl-a-D-mannopyranoside, 0.17 M N-
acetyl-glucosamine, and 0.27 M galactose, pH 7.4 for 30 min. The
amount of fetuin leaving the surface is compared to the original
amount adsorbed
Fig. 7 a–c Affinity chromatography of thyroglobulin on M-LAC,
ConA, and WGA, respectively. Chromatographic conditions are
described in “Materials and Methods.” Bound thyroglobulin was
eluted with solvent B (100 mM acetic acid, pH 4.0), and protein
elution was monitored at 280 nm. The quantitation was performed
using peak area with 1.6%, 21%, and 55% bound to ConA, WGA, and
M-LAC, respectively. d Kinetic data run on LFIRE™ showing the
interaction of circulating thyroglobulin with an immobilized spot
containing equimolar concentrations of ConA/WGA/jacalin compared
to spots containing single lectins, ConA, and WGA. The total binding
to the mixed lectin spot is more than twice the amount of binding to
ConA. Kinetic fit results show the binding affinity about six times
higher for the mixed lectin interaction over ConA and over an order of
magnitude over WGA
44 Clin Proteom (2008) 4:37–46
number of factors including surface chemistry, spot unifor-
mity, good negative controls, quality of the sample, etc. It is
the intention of the authors to show the capabilities for
screening lectin–carbohydrate interactions giving semi-
quantitative results. Although measured affinities are
reproducible within 5% with LFIRE for many interactions
such as antibody–antigen binding, more experimental
controls need to be in place to measure affinity values for
the relatively weak lectin interactions with this degree of
precision.
As an example of the data obtained in the study, Fig. 6
shows the dissociation of fetuin from the lectin spots in the
presence of a cocktail of monosaccharides. Depending on
the lectin composition of the spot, between 30% and 95%
of the fetuin eluted after a 30-min exposure to the cocktail,
far less than expected. Incomplete dissociation may be due
to multivalency effects, and a higher concentration of
saccharide inhibitor, other than the one used in these
studies, may be required to effectively elute the bound
glycoprotein. An extensive series of saccharide inhibition
studies would help clarify these results. Inspection of the
dissociation of the fetuin from the single and paired lectins
yielded a consistent relation. In ascending order, the
dissocations are WGA < WGA + jacalin < jacalin + Con
A < Con A. Such information could aid the design of
chromatographic systems for separating glycoproteins on
columns of immobilized lectins.
We examined the binding affinity of porcine thyroglob-
ulin using single (Con A and WGA) or combinations of
lectins (M-LAC). This glycoprotein contains approximately
10% carbohydrate, present as high mannose and complex-
type oligosaccharides, and thus, has affinity toward ConA
and WGA lectins. Lectin affinity chromatography was
performed as described in materials and methods. The
results are shown in Fig. 7a–c and indicate that the amount
of thyroglobulin bound to M-LAC (55%) is significantly
higher than that of Con A (1.6%) or WGA (21%). The
increased binding observed with the M-LAC is likely due
to multi-site attachment between the glycoprotein and the
different lectins. Lectin–carbohydrate interactions are rela-
tively weak (102–106 M−1); however, in vivo, lectins
exhibit high affinity and specificity for glycoproteins on
the surface of cells [41]. It has been postulated that multiple
protein–carbohydrate interactions act synergistically to
bring about avidity and specificity [42]. To determine if
the combination of lectins leads to stronger binding due to
multivalent interaction, we measured the binding kinetics to
single and multi-lectins.
The kinetic measurements are shown in Fig. 7d and were
performed under identical experimental conditions as the
data shown in Fig. 5. The binding affinity of thyroglobulin
for the mixture of lectins Ka ¼ 2:1 106M1
 
was found
to be about six and 15 times higher over ConA (3.4×
105 M−1) and WGA (1.4×105 M−1), respectively. Although
it is not the scope of this paper to define carbohydrate–
lectin multivalent biochemistry, kinetic analysis using
multiple and single lectins can greatly aid in the selection
of lectin combinations to enrich low-level glycoprotein
markers in complex clinical samples such as plasma or
serum. In ongoing further studies, we are using LFIRE™
imaging ellipsometry as a complementary measurement
tool to multi-lectin affinity chromatography for glycopro-
tein analyses. The combination of both technologies can be
used to reveal subtle differences in glycan-binding specif-
icities of closely related lectins or lectin combinations. For
this purpose, the microarray format is particularly suitable
for studying a single probe’s interaction with a large
number of targets. Hence, this methodology permits
detection of the binding of a specific glycoprotein to a
panel of lectins in a multiplex format to monitor subtle
changes in glycosylation associated with disease. This can
be very relevant in the field of clinical glycoproteomics for
the identification and/or validation of “glyco-markers” in
diseases such as cancer, which are typically associated with
alterations in the amount and type of glycan content. Future
experiments are planned to study the structure–function
relationships of carbohydrate moieties especially in the
discovery of novel clinically relevant biomarkers.
In conclusion, the data suggests that LFIRE™ technol-
ogy can be a useful tool for quantitative and qualitative
analysis of complex kinetic interactions between various
combinations of lectins and glycoproteins. Moreover, by
obviating the need for labels, analyses can be performed
more economically and in parallel using lectin microarrays.
For discovery of potentially significant new biomarkers, the
powerful combination of M-LAC and LFIRE™ offers the
possibility of analyzing lectin–glycoprotein “fingerprints”
or patterns associated with disease occurrence, stage, and/or
response to drugs.
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